Free Trial

Akero Therapeutics (AKRO) Earnings Date, Estimates & Call Transcripts

$27.08
0.00 (0.00%)
(As of 07/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(May. 10)
-$0.90
Consensus EPS
(May. 10)
-$0.90
Skip Charts & View Estimated and Actual Earnings Data

AKRO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AKRO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Akero Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.89)($0.89)($0.89)
Q2 20242($0.95)($0.82)($0.89)
Q3 20242($1.00)($0.87)($0.94)
Q4 20242($1.01)($0.90)($0.96)
FY 20247($3.85)($3.48)($3.67)

AKRO Earnings Date and Information

Akero Therapeutics last announced its quarterly earnings data on May 10th, 2024. The reported ($0.90) earnings per share for the quarter, hitting the consensus estimate of ($0.90). Akero Therapeutics has generated ($3.20) earnings per share over the last year (($3.20) diluted earnings per share). Earnings for Akero Therapeutics are expected to decrease in the coming year, from ($3.82) to ($4.29) per share. Akero Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.

Akero Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2024
(Estimated)
------- 
5/10/2024Q1 2024($0.90)($0.90)-($0.90)--
2/29/2024Q4 2023($0.82)($0.99)($0.17)($0.99)--
11/13/2023Q3 2023($0.70)($0.71)($0.01)($0.71)--
8/11/2023Q2 2023($0.61)($0.60)+$0.01($0.60)--
5/15/2023Q1 2023($0.62)($0.55)+$0.07($0.55)--
3/17/2023Q4 2022($0.78)($0.49)+$0.29($0.49)--
11/4/2022Q3 2022($0.73)($0.92)($0.19)($0.92)--
8/4/2022Q2 2022($0.85)($0.77)+$0.08($0.77)--
5/6/2022Q1 2022($0.85)($0.74)+$0.11($0.74)--
2/25/2022Q4 2021($0.81)($0.93)($0.12)($0.93)--    
11/12/2021Q3 2021($0.91)($0.70)+$0.21($0.70)--
8/12/2021Q2 2021($0.72)($0.83)($0.11)($0.83)--
5/12/2021Q1 2021($0.90)($0.43)+$0.47($0.43)--
3/15/2021Q4 2020($0.59)($0.86)($0.27)($0.86)--
11/17/2020Q3 2020($0.59)($0.63)($0.04)($0.63)--  
8/12/2020Q2 2020($0.6550)($0.57)+$0.0850($0.57)--
5/13/2020Q1 2020($0.6120)($0.42)+$0.1920($0.42)--
3/16/2020Q4 2019($0.59)($0.55)+$0.04($0.55)--
11/12/2019Q3 2019($0.43)($0.56)($0.13)($0.56)--
8/12/2019Q2 2019($0.3630)($2.21)($1.8470)($2.21)--

Akero Therapeutics Earnings - Frequently Asked Questions

When is Akero Therapeutics's earnings date?

Akero Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on AKRO's earnings history.

Did Akero Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Akero Therapeutics (NASDAQ:AKRO) reported ($0.90) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.90). Learn more on analysts' earnings estimate vs. AKRO's actual earnings.

How much profit does Akero Therapeutics generate each year?

Akero Therapeutics (NASDAQ:AKRO) has a recorded net income of -$151.76 million. AKRO has generated -$3.20 earnings per share over the last four quarters.

What is Akero Therapeutics's EPS forecast for next year?

Akero Therapeutics's earnings are expected to decrease from ($3.82) per share to ($4.29) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AKRO) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners